Hugh Paul ONeill - 01 Jan 2026 Form 4 Insider Report for Keenova Therapeutics plc

Role: EVP, Qual & Ops, Spec Brands
Signature: /s/ Mark Tyndall, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2026, 18:03:47 UTC
Previous filing: 04 Aug 2025
Next filing: 26 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ONeill Hugh Paul	EVP, Qual & Ops, Spec Brands	440 ROUTE 22 EAST, SUITE 302, BRIDGEWATER	/s/ Mark Tyndall, Attorney-in-Fact	05 Jan 2026	0002015073

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction		Ordinary Shares	Options Exercise		+2,055	+251%		2,875	01 Jan 2026	Direct	F1
transaction		Ordinary Shares	Tax liability		-1,073	-37%		1,802	01 Jan 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction		Restricted Stock Units	Options Exercise	$0	-2,055	-12%	$0.000000	14,385	01 Jan 2026	Ordinary Shares	2,055		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.
F2	The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market.
F3	On February 2, 2024, the Reporting Person was granted 5,129 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 4 below.
F4	Reflects that the Reporting Person received 2,761 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. ("Par Health") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health.

Remarks:

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.